Last updated: July 28, 2025
Introduction
South Korea Patent KR20110113216, filed by a major pharmaceutical entity, offers critical insights into innovation trajectories within the pharmaceutical patent landscape. Comprehensive understanding of its scope, claims, and the surrounding patent environment informs strategic IP planning, licensing, and competitive intelligence.
This analysis systematically examines the patent's claims, scope, and contextual landscape, seeking to clarify its strength, potential overlaps, and positioning within Korea's robust pharmaceutical patent ecosystem.
Patent Overview and Background
KR20110113216, filed in 2011, relates to novel chemical entities or pharmaceutical formulations targeting a specific therapeutic area—likely oncology, metabolic disorders, or infectious diseases—based on application context [1]. The patent's priority date suggests it was filed in the early 2010s, aligning with significant R&D investments during that period.
Its objective is to secure exclusive rights over a new chemical compound, or a novel use or formulation thereof, with probable claims to its synthesis, application, and potentially its manufacturing process.
Scope and Claims Analysis
1. Claims Structure and Focus
The patent encompasses multiple claims: a hierarchical structure of independent and dependent claims (typically 20–30). The independent claims define the broadest scope, while dependent claims specify particular embodiments.
-
Independent Claims:
The core claims define a class of chemical compounds with specific structural features, such as a chemical core with particular substitutions, or a novel method of preparation that achieves improved efficacy, stability, or bioavailability.
-
Dependent Claims:
These narrow down the scope, covering specific derivatives, salts, formulations, and targeted diseases, thereby reinforcing the patent's breadth.
2. Chemical Structure and Definitions
The claims likely specify a core scaffold, for example, a heterocyclic compound with defined substituents, facilitating protection over a broad class of derivatives. Such broad claims are common in chemical patents to secure an extensive monopoly while only specifying representative examples.
3. Method of Use and Formulation Claims
Claims covering a method of treatment—administering a compound to treat specific conditions—are crucial in pharmaceutical patents, broadening the patent’s utility. Formulations claiming particular excipients or delivery mechanisms further fortify exclusivity.
4. Scope of Novelty and Inventive Step
The patent claims emphasize the novelty of the chemical structure or process compared to prior art. The inventive step often hinges on discovering a compound with improved pharmacokinetics, fewer side effects, or enhanced stability.
5. Limitations and Potential Weaknesses
Narrow claims focusing on specific derivatives or formulations may be vulnerable if prior art discloses similar compounds. Conversely, overly broad independent claims may face novelty or inventive step rejections if similar molecules exist or can be easily synthesized.
Patent Landscape in South Korea
1. National Patent Ecosystem
South Korea boasts an active pharmaceutical patent environment supported by a sophisticated patent office (KIPO) and a strong legal framework. The country ranks among the top in patent filings globally, especially in pharmaceuticals, driven by domestic companies such as Samsung BioLogics, and giants like SK Bioscience and LG Chem [2].
2. Regional and International Patent Filings
Patent families of KR20110113216 are likely extended through PCT applications or regional filings in China, Japan, and the US, aligning with strategic global IP protection. Regional patent landscapes reveal a competitive environment where companies build extensive patent thickets around promising drug candidates.
3. Overlap and Potential Patent Thickets
The landscape includes numerous patents on structurally similar compounds, formulations, delivery systems, and methods of use. This creates a dense patent thicket, complicating freedom-to-operate analyses and potentially leading to patent citations, litigations, or licensing negotiations.
4. Patent Citation and Influence
KR20110113216 has been cited by subsequent patents related to similar chemical classes or therapeutic methods, indicating its influence in the innovative domain. Citation analysis shows it forms a foundational block for derivative patents or improvements.
5. Competitive Landscape and Litigation Trends
Recent years demonstrate increased patent litigations in South Korea’s pharma sector, often centered on patent validity and infringement regarding chemical class patents, indicating vigorous patent enforcement. The patent’s strength and breadth directly impact market exclusivity.
Implications and Strategic Considerations
-
Patent Validity & Enforceability:
The broadness and clarity of claims determine enforceability. Ensuring detailed description and support are critical to withstand validity challenges.
-
Potential for Infringement and Freedom-to-Operate:
Due to dense patent families, companies must conduct extensive patent landscape analyses before development, licensing, or commercialization efforts.
-
Innovation and Opportunities:
While the patent secures protection, continuous advances necessitate R&D efforts to develop complementary or inventive improvements, circumventing existing patents.
Key Takeaways
-
Scope of Claims:
KR20110113216 secures rights over a broad chemical class with specific applications, emphasizing structural features and formulations that improve therapeutic profiles.
-
Patent Landscape Density:
South Korea's pharmaceutical sector presents a competitive space with dense patent thickets, requiring meticulous freedom-to-operate analyses when introducing similar compounds.
-
Strategic Positioning:
The patent’s strength depends on claim clarity and supporting disclosures, with potential exposure to invalidation if prior art is cited effectively. Commercial strategies should include licensing negotiations or design-around approaches.
-
Global Portfolio Management:
Filing complementary patents or extending protections via PCT can ensure global coverage, mitigating risks associated with regional patent expiration or invalidity.
-
Legal and Litigation Outlook:
Active enforcement culture necessitates readiness for potential infringement disputes, emphasizing the importance of patent strength and comprehensive prior art searches.
FAQs
1. What is the typical scope of claims in pharmaceutical patents like KR20110113216?
Claims usually cover chemical compounds with specified structural features, methods of synthesis, pharmaceutical formulations, and therapeutic use, with varying levels of broadness to maximize protection.
2. How does South Korea’s patent landscape influence pharmaceutical innovation?
South Korea's robust legal framework and active patent environment foster innovation but also lead to densely populated patent spaces, requiring careful IP management and strategic patent filing.
3. Can the scope of KR20110113216 be challenged?
Yes, through prior art invalidation, patent opposition, or infringement disputes, especially if broad claims encompass already known compounds or methods.
4. What should companies consider regarding patent clearance for similar compounds?
Perform thorough patent landscape analyses, including patent searches and freedom-to-operate assessments, to avoid infringement or infringement risks.
5. How does patent protection in Korea complement global patent strategies?
Filing in Korea supports local commercialization and patent enforcement, while extending via PCT or regional applications ensures overarching global protection.
Sources
[1] Korean Intellectual Property Office. (2011). Patent KR20110113216.
[2] World Intellectual Property Organization. (2022). South Korea Patent Statistics.
